English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduPeople who identify as lesbian, gay and bisexual – particularly women – respond more positively to tobacco marketing, are more inclined to smoke cigarettes daily and may have a more difficult time quitting, according to two studies by a Rutgers Health researcher.
Tag: Nicotine Addiction
How Adolescents Used Drugs During the COVID-19 Pandemic
Among adolescents ages 10 to 14 in the U.S, the overall rate of drug use remained relatively stable in the first six months of the COVID-19 pandemic. However, one change was a decreased use of alcohol, but an increased use of nicotine and misuse of prescription drugs.
Starting Smoking Cessation in Hospitalized Patients Would Reduce Many Premature Deaths
Each year in the U.S., about 30 million hospitalizations occur in individuals 18 and older. Of these, more than 7 million are current cigarette smokers whose average hospital stay is several days. Researchers say that starting smoking cessation therapy during hospitalization and maintaining high adherence post-discharge can markedly improve permanent quit rates in these patients with minimal to no side effects. Cessation therapy also should include long-term counseling and at least 90 days of a prescription drug, specifically, varenicline.
Take Part in the 2020 Great American Smokeout
November 19, 2020 marks the Great American Smokeout, an annual intervention hosted by the American Cancer Society as a call to action to take the first step towards better health through the elimination of tobacco products. Rutgers experts share more on why and how to get started.
$11.4 million NIH grant advances drug to treat nicotine addiction
Scientists at Sanford Burnham Prebys Medical Discovery Institute, Camino Pharma, LLC and University of California San Diego School of Medicine have been awarded an $11.4 million grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) to advance a novel drug candidate for nicotine addiction into first-in-human Phase 1 studies. The drug targets a neuronal signaling pathway underlying addictive behaviors, and would be a first-in-class medication to help people quit smoking.
Rutgers-Led National Survey Uncovers Doctors’ Misconceptions About Nicotine Risks
Most doctors misperceive the risks of nicotine, the addictive chemical in tobacco products, according to a Rutgers-led national survey.
Study shows need for new focus in anti-vaping efforts for teens & young adults
They know it’s addictive, linked to dangerous lung diseases, and delivers more nicotine than the cigarettes it’s supposed to replace. But the social aspects of vaping drives young people to use e-cigarettes, according to nearly two-thirds of teens and young adults in a new study.